Table 4.

Safety and mortality outcomes

Safety outcomes	N, (%)
Major bleeding during procedure	1 (0.67)
Pulmonary artery injury during procedure	0 (0)
Cardiac tamponade during procedure	0 (0)
Clinical deterioration during the procedure	4 (2.7)
Cardiac arrest during the procedure with successful CPR	1 (0.7)
PE-related death during the procedure	3 (2)
Conversion to open surgery	1 (0.7)
Sustained ventricular tachycardia during the procedure	0 (0)
Sustained supraventricular tachycardia during the procedure	1 (0.67)
Procedure-related death	3 (2)
Major bleeding within 48 h post procedure	2 (1.3)
Hemorrhagic stroke	1 (0.7)
Pulmonary artery injury within 48 h post procedure	0 (0)
Cardiac tamponade within 48 h post procedure	0 (0)
Clinical deterioration within 48 h post procedure	1 (0.7)
PE-related death within 48 h post procedure	0 (0)
All-cause death within 48 h post procedure	0 (0)
Infection (pneumonia/sepsis)	19 (12.7)
Stroke (ischemic/hemorrhagic)	0/1 (0/0.7)
Sustained ventricular tachycardia within 48 h post procedure	0 (0)
Sustained supraventricular tachycardia within 48 h post procedure	4 (2.7)
PE- related mortality within 30 days post procedure	0 (0)
All-cause mortality within 30 days post-procedure	0 (0)
Major bleeding within 30 days post procedure	0 (0)
PE recurrence	0 (0)
PE- related mortality within 90 days post procedure	0 (0)
All-cause mortality within 90 days post procedure	0 (0)
PE recurrence	0 (0)
Major bleeding within 90 days post procedure	0 (0)

PE: pulmonary embolism